This study provides compelling evidence that LCD effectively ameliorates SLE-associated OP progression through coordinated modulation of the NF-κB signaling pathway, inflammatory cytokine networks, and bone remodeling processes in the well-established MRL/lpr mouse model. The gene discussed is NFKB1; the disease is systemic lupus erythematosus.